We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Taisho Pharmaceutical

News List

Taisho Pharmaceutical concludes acquisition of UPSA pharmaceutical-technology
July 03, 2019
Taisho Pharmaceutical has completed an acquisition of Bristol-Myers Squibb’s (BMS) UPSA consumer health business, further supporting its self-medication franchise.
BMS receives offer from Taisho to purchase UPSA cphi-online
January 02, 2019
The potential transaction would position BMS to further refine its portfolio to focus on transformational medicines for patients facing serious diseases.
Bristol-Myers Squibb hands Upsa consumer biz to Taisho for $1.6B fiercepharma
December 20, 2018
When it rains, it pours. Just as Pfizer and GlaxoSmithKline teamed up on an industry-leading consumer health joint venture, Bristol-Myers Squibb struck its own deal in the sector.